// App-Quantinova.ai

1220-100 : EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL

Researchers

Presenter

  • Sameer Bansilal

Principal Investigators

  • Marc Bonaca

  • J.H. Cornel

  • Ton Oude Ophuis

  • Robert Storey

  • Deepak Bhatt

  • Philippe Steg

  • Kelly Im

  • Peter Held

  • Eva Jensen

  • Eugene Braunwald

  • Marc Sabatine

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Coronary Artery Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Microvessel density

  • Protein Tyrosine Phosphatase, Non-Receptor Type 22

Drug/Treatment

  • Ticagrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved